Page last updated: 2024-09-03

y 27632 and Pulmonary Arterial Hypertension

y 27632 has been researched along with Pulmonary Arterial Hypertension in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Affatato, R; Cantoni, S; Ceriani, S; De Giorgio, D; De Logu, F; Facchinetti, F; Fumagalli, F; Latini, R; Letizia, T; Masson, S; Milioli, M; Nassini, R; Novelli, D; Olivari, D; Ristagno, G; Russo, I; Salio, M; Staszewsky, L; Trevisani, M	1

Other Studies

1 other study(ies) available for y 27632 and Pulmonary Arterial Hypertension

Article	Year
Monocrotaline-induced pulmonary arterial hypertension: Time-course of injury and comparative evaluation of macitentan and Y-27632, a Rho kinase inhibitor. European journal of pharmacology, 2019, Dec-15, Volume: 865 Topics: Amides; Animals; Endothelin Receptor Antagonists; Heart Ventricles; Hemodynamics; Hypertrophy, Right Ventricular; Male; Monocrotaline; Protein Kinase Inhibitors; Pulmonary Arterial Hypertension; Pulmonary Artery; Pyridines; Pyrimidines; Rats, Wistar; rho-Associated Kinases; Sulfonamides	2019

Article

Year

Monocrotaline-induced pulmonary arterial hypertension: Time-course of injury and comparative evaluation of macitentan and Y-27632, a Rho kinase inhibitor.

European journal of pharmacology, 2019, Dec-15, Volume: 865

Topics: Amides; Animals; Endothelin Receptor Antagonists; Heart Ventricles; Hemodynamics; Hypertrophy, Right Ventricular; Male; Monocrotaline; Protein Kinase Inhibitors; Pulmonary Arterial Hypertension; Pulmonary Artery; Pyridines; Pyrimidines; Rats, Wistar; rho-Associated Kinases; Sulfonamides

2019